May 6, 2026 05:16PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance

Apr 23, 2026 09:24AM Tarsus Pharmaceuticals (TARS) PT Lowered to $100 at Mizuho

Mar 25, 2026 01:36PM Tarsus Pharmaceuticals (TARS) PT Raised to $101 at Mizuho

Mar 23, 2026 09:51AM William Blair on Tarsus Pharmaceuticals (TARS): 'benefits from the large and motivated patient population'

Mar 23, 2026 08:32AM Tarsus receives $15M milestone after China approves TP-03 eye treatment

Feb 24, 2026 12:44AM Tarsus Pharmaceuticals, Inc. (TARS) Misses Q4 EPS by 12c

Nov 20, 2025 05:36AM Mizuho Starts Tarsus Pharmaceuticals (TARS) at Outperform, 'Mite Be a Blockbuster: Bullish on Xdemvy'

Nov 4, 2025 04:28PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q3 EPS by 5c

Oct 20, 2025 06:09AM Tarsus Pharmaceuticals (TARS) PT Raised to $88 at H.C. Wainwright

Aug 6, 2025 06:21PM Tarsus Pharmaceuticals, Inc. (TARS) Misses Q2 EPS by 10c

Jun 2, 2025 08:56AM Oppenheimer assumes Tarsus Pharmaceuticals (TARS) at Outperform (correction)

May 27, 2025 06:06AM H.C. Wainwright Starts Tarsus Pharmaceuticals (TARS) at Buy

May 5, 2025 07:39AM Elanco Animal Health (ELAN) sells certain royalties and commercial milestones associated with XDEMVY to Blackstone Life Sciences and Blackstone Credit & Insurance for $295M Cash

Mar 12, 2025 04:13PM Tarsus Pharmaceuticals (TARS) Announces Proposed $100M Public Offering

Mar 6, 2025 12:59PM Tarsus Pharmaceuticals (TARS) PT Raised to $58 at Jefferies

Feb 26, 2025 07:26AM Tarsus Pharmaceuticals (TARS) PT Raised to $78 at Guggenheim

Feb 26, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)

Feb 25, 2025 04:27PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q4 EPS by 17c

Jan 22, 2025 06:27AM Tarsus Pharmaceuticals (TARS) PT Raised to $72 at Oppenheimer

Jan 15, 2025 05:04AM Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)

Jan 13, 2025 08:37AM Tarsus Pharmaceuticals (TARS) Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

Nov 29, 2024 08:31AM Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)

Nov 15, 2024 06:51AM Tarsus Pharmaceuticals (TARS) PT Raised to $73 at H.C. Wainwright

Nov 13, 2024 05:34PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q3 EPS by 33c

Nov 13, 2024 08:30AM Tarsus Pharmaceuticals (TARS) Appoints Kate Goodrich to its Board

Nov 5, 2024 08:30AM Tarsus Pharmaceuticals (TARS) Appoints Elizabeth Yeu as Chief Medical Officer

Oct 22, 2024 06:27AM Oppenheimer Reiterates Outperform Rating on Tarsus Pharmaceuticals (TARS)

Oct 11, 2024 07:23AM Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)

Oct 4, 2024 06:55AM Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)

Sep 23, 2024 07:33AM Oppenheimer Reiterates Outperform Rating on Tarsus Pharmaceuticals (TARS)

Aug 9, 2024 06:37AM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q2 EPS by 4c

Feb 9, 2024 08:00PM 4 small and mid-cap biopharma stocks to own according to BofA